Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 known ✓ | P13945 | 14/20 | 0.98 |
| ▸ | ADRB2 known ✓ | P07550 | 11/20 | 0.98 |
| ▸ | ADRB1 known ✓ | P08588 | 8/20 | 0.98 |
| ▸ | ADRA1D known ✓ | P25100 | 1/20 | 0.81 |
| ▸ | ADRA1A known ✓ | P35348 | 1/20 | 0.81 |
| ▸ | ADRA1B known ✓ | P35368 | 1/20 | 0.81 |
| ▸ | GLA | P06280 | 1/20 | 0.98 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.81 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.81 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.81 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.81 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.79 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.79 |
| ▸ | SLC2A1 | P11166 | 4/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL9317314 | 1.00 | ADRB3 (0.98) | ADRB3ADRB2ADRB1GLACYP2D6 | |
| Bromide SCHEMBL29460100 | 1.00 | ADRB3 (0.98) | ADRB3ADRB2ADRB1GLACYP2D6 | |
| SCHEMBL5144153 | 0.99 | ADRB3 (1.00) | ADRB3ADRB2ADRB1GLACYP2D6 | |
| SCHEMBL4611391 | 0.99 | ADRB3 (1.00) | ADRB3ADRB2ADRB1GLACYP2D6 | |
| SCHEMBL5144149 | 0.99 | ADRB3 (1.00) | ADRB3ADRB2ADRB1GLACYP2D6 | |
| SCHEMBL9006835 | 0.99 | ADRB3 (1.00) | ADRB3ADRB2ADRB1GLACYP2D6 | |
| SCHEMBL5144151 | 0.99 | ADRB3 (1.00) | ADRB3ADRB2ADRB1GLACYP2D6 | |
| Trifluoroacetic Acid SCHEMBL9318455 | 0.93 | ADRB3 (0.89) | ADRB3ADRB2ADRB1GLACYP2D6 | |
| SCHEMBL9812024 | 0.90 | ADRB3 (0.84) | ADRB3ADRB2ADRB1GLACYP2D6 | |
| SCHEMBL9812022 | 0.90 | ADRB3 (0.84) | ADRB3ADRB2ADRB1GLACYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0170135-B1 | NOVEL MORPHOLINES | BEECHAM GROUP PLC (GB) | 1991-03-20 | — | — | EP | disclosed |
| US-4803293-A | Tertiary amines | BEECHAM GROUP PLC (GB) | 1989-02-07 | — | — | US | disclosed |
| EP-0142102-B1 | TERTIARY AMINES | BEECHAM GROUP PLC (GB) | 1987-09-23 | — | — | EP | disclosed |
| US-4596800-A | Hypoglycaemic agents | BEECHAM GROUP P.L.C. (GB) | 1986-06-24 | — | — | US | disclosed |
| US-4593023-A | Antiobesity, hypoglycemic agent | BEECHAM GROUP P.L.C. (GB) | 1986-06-03 | — | — | US | disclosed |
| EP-0171519-A2 | 6-Oxomorpholine derivatives, process for their preparation, intermediates, and pharmaceutical compositions containing these derivatives | BEECHAM GROUP PLC (GB) | 1986-02-19 | — | — | EP | disclosed |
| EP-0170135-A1 | Novel Morpholines | BEECHAM GROUP PLC (GB) | 1986-02-05 | — | — | EP | disclosed |
| EP-0142102-A2 | Tertiary amines | BEECHAM GROUP PLC (GB) | 1985-05-22 | — | — | EP | disclosed |